HNF4A and bacterial infectious disease: Previous studies have shown that Caenorhabditis elegans NHR-86, a mammalian HNF4 homolog, is not required for basal resistance to Pseudomonas aeruginosa but can be activated by immunostimulatory small molecules to drive a protective transcriptional program against bacterial infection [42].